HB0034 in Patients With Generalized Pustular Psoriasis (GPP)

Study Evaluating the Safety and Efficacy of Etanercept 50 mg Once Weekly in Subjects With Psoriasis

NCT00333034 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate Efficacy and Safety of HS-10374 for Mild-to-moderate Plaque Psoriasis

NCT06926582 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Study of JNJ-77242113 for the Treatment of Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis

NCT06295692 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study of HB0017 in Patients With Moderate to Severe Plaque Psoriasis

NCT05442788 ·Status: COMPLETED ·Phase: PHASE1

A Phase 2 Study of HB0017 in Psoriasis Patients

NCT06592274 ·Status: RECRUITING ·Phase: PHASE2

Efficacy and Safety of HS-10374 Compared to Placebo in Adults With Active Psoriatic Arthritis

NCT06176508 ·Status: RECRUITING ·Phase: PHASE2

Study of Efficacy and Safety of HB0017 in Patients With Moderate to Severe Plaque Psoriasis

NCT06477237 ·Status: RECRUITING ·Phase: PHASE3

Evaluate the Safety and Pharmacokinetics/Pharmacodynamics and Food Effect of HS-20118

NCT07033234 ·Status: RECRUITING ·Phase: PHASE1

A Trial Comparing SHR-1139 Injection With Placebo in Patients With Moderate-to-severe Plaque Psoriasis

NCT06875934 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Study to Investigate Efficacy and Safety of Adalimumab in Japanese Subjects With Generalized Pustular Psoriasis (GPP)

NCT02533375 ·Status: COMPLETED ·Phase: PHASE3

Study to Assess the Efficacy, Safety and Tolerability of Secukinumab in Japanese Subjects With Generalized Pustular Psoriasis (GPP)

NCT01952015 ·Status: COMPLETED ·Phase: PHASE3

A Study of Guselkumab for the Treatment of Palmoplantar-non-Pustular Psoriasis

NCT03998683 ·Status: COMPLETED ·Phase: PHASE3

A Safety Study of Multiple Subcutaneous (s.c.) Injections of SHR-1314 in Adults With Moderate-to-severe Plaque Psoriasis

NCT03710681 ·Status: UNKNOWN ·Phase: PHASE1

Evaluate the Safety and Pharmacokinetics/Pharmacodynamics of HS-20118

NCT06846710 ·Status: RECRUITING ·Phase: PHASE1

A Phase I Clinical Trial of Single Subcutaneous Injection or Intravenous Infusion of SHR-1139 Injection in Healthy Chinese Subjects and Multiple Subcutaneous Injections in Patients With Moderate-to-severe Plaque Psoriasis

NCT07051538 ·Status: COMPLETED ·Phase: PHASE1

Efficacy 、Safety and PK of SHR-1314 in Patients With Moderate-to-Severe Plaque Psoriasis

NCT04839016 ·Status: UNKNOWN ·Phase: PHASE3

Evaluating the Safety of Etanercept 50 mg Twice Weekly in Subjects With Psoriasis

NCT00111449 ·Status: COMPLETED ·Phase: PHASE3

ACT-128800 in Psoriasis

NCT00852670 ·Status: COMPLETED ·Phase: PHASE2

Multi-Dose Study of SHR-1314 in Subjects With Moderate-to-severe Plaque Psoriasis

NCT03463187 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

PMS of Spesolimab I.V. in GPP Patients With Acute Symptoms

NCT05670821 ·Status: COMPLETED

A Study to Evaluate Efalizumab in Adults With Plaque Psoriasis, Including Those Who Are Receiving Concomitant Antipsoriatic Therapies

NCT00338143 ·Status: COMPLETED ·Phase: PHASE3

A Study to Investigate Efficacy and Safety of Apremilast 30 mg Twice Daily (BID) in Chinese Participants With Moderate to Severe Plaque-type Psoriasis (PsO)

NCT06122649 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of Multiple Doses of BT061 in Patients With Moderate to Severe Chronic Plaque Psoriasis

NCT01072383 ·Status: COMPLETED ·Phase: PHASE2

Etanercept Plus UVB-311nm Phototherapy in Psoriasis

NCT00550030 ·Status: COMPLETED ·Phase: NA

Safety and Efficacy of Etanercept in Patients With Psoriasis Who Failed to Respond to Other Biologic Treatments

NCT00967538 ·Status: COMPLETED ·Phase: PHASE4